During a House Oversight Committee hearing titled "Amnesty and Chaos: Abuse of U.S. Immigration Policy," Representative James Walkinshaw (D-VA) gave his Republican colleagues an example of "chaos" by ...

"The Legend of Vox Machina" Season 4 (Credit: Prime Video) “The Legend of Vox Machina” Season 4 kicks off June’s new arrivals for Amazon’s Prime Video. The latest season of the hit Critical Role ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

It’s already June, which means a slew of new content is being added to popular streamers like Netflix, HBO Max, Hulu and more. Prime Video is no different, as the Jeff Bezos-owned platform is looking ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Prime Video's got a small selection of Original titles heading to the ...

Join the Tom's Guide Club for quick access. Enter your email below and we'll send confirmation, and sign you up to our newsletter.

The first Minecraft 26.2 pre-release is here for Java Edition, but there's some bad news if you've been taking advantage of the sandbox game's new peer-to-peer multiplayer, which was implemented in a ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the 10 Best Penny Stocks to Buy for Long Term. On May 14, 2026, Morgan Stanley raised the firm’s price target on Recursion Pharmaceuticals, Inc.

In a rare direct address, Secretary of State Marco Rubio blamed the former leader Raúl Castro for the country’s longstanding electricity and resource shortages. By Ali Watkins Secretary of State Marco ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

"For 2026, we are maintaining our cash operating expense guidance of less than $390 million." (CFO & President of Recursion UK Taylor). "We expect multiple clinical readouts over the next 12 to 18 ...